Global Medical Nonwovens Market - Trends and Forecast to 2024
Synopsis:
Global Medical Nonwovens Market is expected to reach USD 9,523.9 billion by 2024, at a CAGR of 6.0% during the forecast period of 2017 to 2024. The report contains 258 pages of exclusive premium insights with 235 tables and 25 figures.
Medical nonwovens are used majorly in medical fields such as surgical gowns, surgical glows, surgical masks, diapers, etc. They are designed in order to provide safety from infections and diseases. Nonwovens have bacterial barrier properties for the products such as surgical masks, gowns and drapes. The demand for healthcare is beginning to increase and it is expected to help sustain the growth of nonwovens use. Medical nonwovens are unique and are used widely in a range of consumer and industrial products with absorbent hygiene products, apparel, healthcare and surgical fabrics and, wipes. According to survey conducted by the nonwovens industry, Asia Pacific is the highest growing region in the use of medical nonwovens. Hygiene products manufacturers have the largest consumer segment of disposable nonwovens mainly due to the large baby diaper, toddler training pants and feminine hygiene markets. The value for disposable nonwovens is growing faster than the value for durable products as the growing upper and middle class population in the central Asian markets are in demand for higher performance, higher value consumer goods like diapers, feminine hygiene products and medical materials have move away from lower cost, lower quality entry level products.
The global medical nonwovens market have been segmented On the basis of type into spunbond, meltblown, drylaid, wetlaid and spun-melt-spun (SMS).
Based on product type the market is segmented into hygiene and apparel products.
On the basis of end-user the market is segmented into hospitals, clinics, home healthcare, laboratories and ambulatory surgical centers.
Based on distribution channel the market is segmented into direct tenders and retail.
The global medical nonwovens market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 29 major countries such as United States of America, Canada, Mexico, Germany, France, United Kingdom, Italy, Spain,Switzerland, Netherlands, Turkey, Belgium, Russia, Rest of Europe, Japan, China, India, South Korea, Australia,Thailand, Malaysia, Singapore, Philippines, Indonesia, Rest of APAC, Brazil, Rest of South America, South Africa and Rest of MEA.
Major Players Operating in this market:
3M, KCWW, Avintiv, Halyard Health, Inc.,Freudenberg Performance Materials, Advanced Fabrics (SAAF), Biovation LLC, Intco Medical, Ahlstrom Corporation,Ansell Healthcare, Asahi Kasei Corporation, B. Braun Melsungen AG, Medtronic, Cypress Medical Products,Dynarex Corporation, Georgia-Pacific, Hogy Medical, Molnlycke Health Care AB, Paul Hartmann AG, Precision Fabrics Group, Inc., Domtar Corporation, Cardinal Health, UniCharm Corporation, Kraton Performance Polymers Inc., and Medline Industries, Inc. among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))
Global Medical Nonwovens Market is expected to reach USD 9,523.9 billion by 2024, at a CAGR of 6.0% during the forecast period of 2017 to 2024. The report contains 258 pages of exclusive premium insights with 235 tables and 25 figures.
Medical nonwovens are used majorly in medical fields such as surgical gowns, surgical glows, surgical masks, diapers, etc. They are designed in order to provide safety from infections and diseases. Nonwovens have bacterial barrier properties for the products such as surgical masks, gowns and drapes. The demand for healthcare is beginning to increase and it is expected to help sustain the growth of nonwovens use. Medical nonwovens are unique and are used widely in a range of consumer and industrial products with absorbent hygiene products, apparel, healthcare and surgical fabrics and, wipes. According to survey conducted by the nonwovens industry, Asia Pacific is the highest growing region in the use of medical nonwovens. Hygiene products manufacturers have the largest consumer segment of disposable nonwovens mainly due to the large baby diaper, toddler training pants and feminine hygiene markets. The value for disposable nonwovens is growing faster than the value for durable products as the growing upper and middle class population in the central Asian markets are in demand for higher performance, higher value consumer goods like diapers, feminine hygiene products and medical materials have move away from lower cost, lower quality entry level products.
The global medical nonwovens market have been segmented On the basis of type into spunbond, meltblown, drylaid, wetlaid and spun-melt-spun (SMS).
Based on product type the market is segmented into hygiene and apparel products.
On the basis of end-user the market is segmented into hospitals, clinics, home healthcare, laboratories and ambulatory surgical centers.
Based on distribution channel the market is segmented into direct tenders and retail.
The global medical nonwovens market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 29 major countries such as United States of America, Canada, Mexico, Germany, France, United Kingdom, Italy, Spain,Switzerland, Netherlands, Turkey, Belgium, Russia, Rest of Europe, Japan, China, India, South Korea, Australia,Thailand, Malaysia, Singapore, Philippines, Indonesia, Rest of APAC, Brazil, Rest of South America, South Africa and Rest of MEA.
Major Players Operating in this market:
3M, KCWW, Avintiv, Halyard Health, Inc.,Freudenberg Performance Materials, Advanced Fabrics (SAAF), Biovation LLC, Intco Medical, Ahlstrom Corporation,Ansell Healthcare, Asahi Kasei Corporation, B. Braun Melsungen AG, Medtronic, Cypress Medical Products,Dynarex Corporation, Georgia-Pacific, Hogy Medical, Molnlycke Health Care AB, Paul Hartmann AG, Precision Fabrics Group, Inc., Domtar Corporation, Cardinal Health, UniCharm Corporation, Kraton Performance Polymers Inc., and Medline Industries, Inc. among others.
Regions Covered In The Scope Of The Report:
Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))
1 INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL MEDICAL NONWOVENS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL MEDICAL NONWOVENS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. PRODUCT PIPELINE ANALYSIS
2.2.6. PORTER’S FIVE FORCES MATRIX
2.4. GLOBAL MEDICAL NONWOVENS MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL MEDICAL NONWOVENS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. COST REDUCTION IN HEALTHCARE
4.3.1.2. TECHNOLOGICALLY BENEFICIAL
4.3.1.3. INCREASING THREAT OF HOSPITAL AQUIRED INFECTION
4.3.1.4. INCREASING DEMAND FOR MODERN HEALTHCARE IN ASIA
4.3.1.5. RISING ACCEPTANCE OF HOME HEALTHCARE
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 MEDICAL NONWOVENS MARKET, BY TYPE
5.1. OVERVIEW
5.2. SPUNBOND
5.3. MELTBLOWN
5.4. DRYLAID
5.5. WETLAID
5.6. SPUN-MELT-SPUN (SMS)
6 MEDICAL NONWOVENS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. HYGIENE TECHNOLOGY, BY PRODUCT TYPE
6.2.1. INCONTINENCE PADS
6.2.2. OSTOMY LINERS
6.2.3. DISPOSABLE UNDERWEARS
6.2.4. CSR WRAPS
6.2.5. DISPOSABLE MEDICAL WIPES
6.2.6. DIAPERS
6.3. APPAREL PRODUCTS, BY PRODUCT TYPE
6.3.1. SURGICAL MASKS
6.3.2. SURGICAL PACKS
6.3.3. SURGICAL DRAPES AND GOWNS
6.3.4. SURGICAL CAPS
6.3.5. WOUND CARE MATERIAL
6.3.6. OTHERS
7 MEDICAL NONWOVENS MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. CLINICS
7.4. HOME HEALTHCARE
7.5. LABORATORY
7.6. AMBULATORY SURGICAL CENTERS
7.6. OTHERS
8 MEDICAL NONWOVENS MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DIRECT TENDERS
8.3. RETAIL
9 MEDICAL NONWOVENS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE MEDICAL NONWOVENS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10 MEDICAL NONWOVENS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.4. APAC MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.10. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11 MEDICAL NONWOVENS MARKET, COMPANY PROFILES
11.1 KIMBERLY-CLARK CORPORATION
11.1.1 COMPANY OVERVIEW
11.1.2 SWOT ANALYSIS
11.1.3 REVENUE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPEMENTS
11.1.5 DATA BRIDGE ANALYSIS
11.2 AVINTIV INC.
11.2.1 COMPANY OVERVIEW
11.2.2 SWOT ANALYSIS
11.2.3 REVENUE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPEMENTS
11.2.5 DATA BRIDGE ANALYSIS
11.3 HALYARD HEALTH, INC.
11.3.1 COMPANY OVERVIEW
11.3.2 SWOT ANALYSIS
11.3.3 REVENUE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPEMENTS
11.3.5 DATA BRIDGE ANALYSIS
11.4 FREUDENBERG PERFORMANCE MATERIALS
11.4.1 COMPANY OVERVIEW
11.4.2 SWOT ANALYSIS
11.4.3 REVENUE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPEMENTS
11.4.5 DATA BRIDGE ANALYSIS
11.5 ADVANCED FABRICS (SAAF)
11.5.1 COMPANY OVERVIEW
11.5.2 SWOT ANALYSIS
11.5.3 REVENUE ANALYSIS
11.5.4 PRODUCT PORTFOLIO
11.5.5 RECENT DEVELOPEMENTS
11.5.5 DATA BRIDGE ANALYSIS
11.6 BIOVATION LLC
11.6.1 COMPANY OVERVIEW
11.6.2 SWOT ANALYSIS
11.6.3 REVENUE ANALYSIS
11.6.4 PRODUCT PORTFOLIO
11.6.5 RECENT DEVELOPEMENTS
11.6.5 DATA BRIDGE ANALYSIS
11.7 INTCO MEDICAL
11.7.1 COMPANY OVERVIEW
11.7.2 SWOT ANALYSIS
11.7.3 REVENUE ANALYSIS
11.7.4 PRODUCT PORTFOLIO
11.7.5 RECENT DEVELOPEMENTS
11.7.5 DATA BRIDGE ANALYSIS
11.8 AHLSTROM CORPORATION
11.8.1 COMPANY OVERVIEW
11.8.2 SWOT ANALYSIS
11.8.3 REVENUE ANALYSIS
11.8.4 PRODUCT PORTFOLIO
11.8.5 RECENT DEVELOPEMENTS
11.8.5 DATA BRIDGE ANALYSIS
11.9 ANSELL HEALTHCARE
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.5 DATA BRIDGE ANALYSIS
11.9 ASAHI KASEI CORPORATION
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.5 DATA BRIDGE ANALYSIS
11.9 B. BRAUN MELSUNGEN AG
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.5 DATA BRIDGE ANALYSIS
11.10 MEDTRONIC
11.10.1 COMPANY OVERVIEW
11.10.2 SWOT ANALYSIS
11.10.3 REVENUE ANALYSIS
11.10.4 PRODUCT PORTFOLIO
11.10.5 RECENT DEVELOPEMENTS
11.10.5 DATA BRIDGE ANALYSIS
11.11 CYPRESS MEDICAL PRODUCTS
11.11.1 COMPANY OVERVIEW
11.11.2 SWOT ANALYSIS
11.11.3 REVENUE ANALYSIS
11.11.4 PRODUCT PORTFOLIO
11.11.5 RECENT DEVELOPEMENTS
11.11.5 DATA BRIDGE ANALYSIS
11.12 DYNAREX CORPORATION
11.12.1 COMPANY OVERVIEW
11.12.2 SWOT ANALYSIS
11.12.3 REVENUE ANALYSIS
11.12.4 PRODUCT PORTFOLIO
11.12.5 RECENT DEVELOPEMENTS
11.12.5 DATA BRIDGE ANALYSIS
11.13 GEORGIA-PACIFIC
11.13.1 COMPANY OVERVIEW
11.13.2 SWOT ANALYSIS
11.13.3 REVENUE ANALYSIS
11.13.4 PRODUCT PORTFOLIO
11.13.5 RECENT DEVELOPEMENTS
11.13.5 DATA BRIDGE ANALYSIS
11.14 HOGY MEDICAL
11.14.1 COMPANY OVERVIEW
11.14.2 SWOT ANALYSIS
11.14.3 REVENUE ANALYSIS
11.14.4 PRODUCT PORTFOLIO
11.14.5 RECENT DEVELOPEMENTS
11.14.5 DATA BRIDGE ANALYSIS
11.15 MOLNLYCKE HEALTH CARE AB
11.15.1 COMPANY OVERVIEW
11.15.2 SWOT ANALYSIS
11.15.3 REVENUE ANALYSIS
11.15.4 PRODUCT PORTFOLIO
11.15.5 RECENT DEVELOPEMENTS
11.15.5 DATA BRIDGE ANALYSIS
11.16 PAUL HARTMANN AG
11.16.1 COMPANY OVERVIEW
11.16.2 SWOT ANALYSIS
11.16.3 REVENUE ANALYSIS
11.16.4 PRODUCT PORTFOLIO
11.16.5 RECENT DEVELOPEMENTS
11.16.5 DATA BRIDGE ANALYSIS
11.17 PRECISION FABRICS GROUP, INC
11.17.1 COMPANY OVERVIEW
11.17.2 SWOT ANALYSIS
11.17.3 REVENUE ANALYSIS
11.17.4 PRODUCT PORTFOLIO
11.17.5 RECENT DEVELOPEMENTS
11.17.5 DATA BRIDGE ANALYSIS
11.18 DOMTAR CORPORATION
11.18.1 COMPANY OVERVIEW
11.18.2 SWOT ANALYSIS
11.18.3 REVENUE ANALYSIS
11.18.4 PRODUCT PORTFOLIO
11.18.5 RECENT DEVELOPEMENTS
11.18.5 DATA BRIDGE ANALYSIS
11.19 CARDINAL HEALTH
11.19.1 COMPANY OVERVIEW
11.19.2 SWOT ANALYSIS
11.19.3 REVENUE ANALYSIS
11.19.4 PRODUCT PORTFOLIO
11.19.5 RECENT DEVELOPEMENTS
11.19.5 DATA BRIDGE ANALYSIS
11.20 UNICHARM CORPORATION
11.20.1 COMPANY OVERVIEW
11.20.2 SWOT ANALYSIS
11.20.3 REVENUE ANALYSIS
11.20.4 PRODUCT PORTFOLIO
11.20.5 RECENT DEVELOPEMENTS
11.20.5 DATA BRIDGE ANALYSIS
11.21 KRATON PERFORMANCE POLYMERS INC.
11.21.1 COMPANY OVERVIEW
11.21.2 SWOT ANALYSIS
11.21.3 REVENUE ANALYSIS
11.21.4 PRODUCT PORTFOLIO
11.21.5 RECENT DEVELOPEMENTS
11.21.5 DATA BRIDGE ANALYSIS
11.22 WONDERFUL NONWOVEN COMPANY
11.22.1 COMPANY OVERVIEW
11.22.2 SWOT ANALYSIS
11.22.3 REVENUE ANALYSIS
11.22.4 PRODUCT PORTFOLIO
11.22.5 RECENT DEVELOPEMENTS
11.22.5 DATA BRIDGE ANALYSIS
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH
1.1. OVERVIEW OF THE GLOBAL MEDICAL NONWOVENS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL MEDICAL NONWOVENS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. PRODUCT PIPELINE ANALYSIS
2.2.6. PORTER’S FIVE FORCES MATRIX
2.4. GLOBAL MEDICAL NONWOVENS MARKET: RESEARCH SNAPSHOT
2.5. ASSUMPTIONS
3 MARKET LANDSCAPE SUMMARY
4 PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL MEDICAL NONWOVENS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. COST REDUCTION IN HEALTHCARE
4.3.1.2. TECHNOLOGICALLY BENEFICIAL
4.3.1.3. INCREASING THREAT OF HOSPITAL AQUIRED INFECTION
4.3.1.4. INCREASING DEMAND FOR MODERN HEALTHCARE IN ASIA
4.3.1.5. RISING ACCEPTANCE OF HOME HEALTHCARE
4.3.2. RESTRAINTS
4.3.3. OPPURTUNITIES
4.3.4. THREATS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5 MEDICAL NONWOVENS MARKET, BY TYPE
5.1. OVERVIEW
5.2. SPUNBOND
5.3. MELTBLOWN
5.4. DRYLAID
5.5. WETLAID
5.6. SPUN-MELT-SPUN (SMS)
6 MEDICAL NONWOVENS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. HYGIENE TECHNOLOGY, BY PRODUCT TYPE
6.2.1. INCONTINENCE PADS
6.2.2. OSTOMY LINERS
6.2.3. DISPOSABLE UNDERWEARS
6.2.4. CSR WRAPS
6.2.5. DISPOSABLE MEDICAL WIPES
6.2.6. DIAPERS
6.3. APPAREL PRODUCTS, BY PRODUCT TYPE
6.3.1. SURGICAL MASKS
6.3.2. SURGICAL PACKS
6.3.3. SURGICAL DRAPES AND GOWNS
6.3.4. SURGICAL CAPS
6.3.5. WOUND CARE MATERIAL
6.3.6. OTHERS
7 MEDICAL NONWOVENS MARKET, BY END-USER
7.1. OVERVIEW
7.2. HOSPITALS
7.3. CLINICS
7.4. HOME HEALTHCARE
7.5. LABORATORY
7.6. AMBULATORY SURGICAL CENTERS
7.6. OTHERS
8 MEDICAL NONWOVENS MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DIRECT TENDERS
8.3. RETAIL
9 MEDICAL NONWOVENS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE MEDICAL NONWOVENS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10 MEDICAL NONWOVENS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.4. APAC MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA MEDICAL NONWOVENS MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.10. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11 MEDICAL NONWOVENS MARKET, COMPANY PROFILES
11.1 KIMBERLY-CLARK CORPORATION
11.1.1 COMPANY OVERVIEW
11.1.2 SWOT ANALYSIS
11.1.3 REVENUE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPEMENTS
11.1.5 DATA BRIDGE ANALYSIS
11.2 AVINTIV INC.
11.2.1 COMPANY OVERVIEW
11.2.2 SWOT ANALYSIS
11.2.3 REVENUE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPEMENTS
11.2.5 DATA BRIDGE ANALYSIS
11.3 HALYARD HEALTH, INC.
11.3.1 COMPANY OVERVIEW
11.3.2 SWOT ANALYSIS
11.3.3 REVENUE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPEMENTS
11.3.5 DATA BRIDGE ANALYSIS
11.4 FREUDENBERG PERFORMANCE MATERIALS
11.4.1 COMPANY OVERVIEW
11.4.2 SWOT ANALYSIS
11.4.3 REVENUE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPEMENTS
11.4.5 DATA BRIDGE ANALYSIS
11.5 ADVANCED FABRICS (SAAF)
11.5.1 COMPANY OVERVIEW
11.5.2 SWOT ANALYSIS
11.5.3 REVENUE ANALYSIS
11.5.4 PRODUCT PORTFOLIO
11.5.5 RECENT DEVELOPEMENTS
11.5.5 DATA BRIDGE ANALYSIS
11.6 BIOVATION LLC
11.6.1 COMPANY OVERVIEW
11.6.2 SWOT ANALYSIS
11.6.3 REVENUE ANALYSIS
11.6.4 PRODUCT PORTFOLIO
11.6.5 RECENT DEVELOPEMENTS
11.6.5 DATA BRIDGE ANALYSIS
11.7 INTCO MEDICAL
11.7.1 COMPANY OVERVIEW
11.7.2 SWOT ANALYSIS
11.7.3 REVENUE ANALYSIS
11.7.4 PRODUCT PORTFOLIO
11.7.5 RECENT DEVELOPEMENTS
11.7.5 DATA BRIDGE ANALYSIS
11.8 AHLSTROM CORPORATION
11.8.1 COMPANY OVERVIEW
11.8.2 SWOT ANALYSIS
11.8.3 REVENUE ANALYSIS
11.8.4 PRODUCT PORTFOLIO
11.8.5 RECENT DEVELOPEMENTS
11.8.5 DATA BRIDGE ANALYSIS
11.9 ANSELL HEALTHCARE
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.5 DATA BRIDGE ANALYSIS
11.9 ASAHI KASEI CORPORATION
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.5 DATA BRIDGE ANALYSIS
11.9 B. BRAUN MELSUNGEN AG
11.9.1 COMPANY OVERVIEW
11.9.2 SWOT ANALYSIS
11.9.3 REVENUE ANALYSIS
11.9.4 PRODUCT PORTFOLIO
11.9.5 RECENT DEVELOPEMENTS
11.9.5 DATA BRIDGE ANALYSIS
11.10 MEDTRONIC
11.10.1 COMPANY OVERVIEW
11.10.2 SWOT ANALYSIS
11.10.3 REVENUE ANALYSIS
11.10.4 PRODUCT PORTFOLIO
11.10.5 RECENT DEVELOPEMENTS
11.10.5 DATA BRIDGE ANALYSIS
11.11 CYPRESS MEDICAL PRODUCTS
11.11.1 COMPANY OVERVIEW
11.11.2 SWOT ANALYSIS
11.11.3 REVENUE ANALYSIS
11.11.4 PRODUCT PORTFOLIO
11.11.5 RECENT DEVELOPEMENTS
11.11.5 DATA BRIDGE ANALYSIS
11.12 DYNAREX CORPORATION
11.12.1 COMPANY OVERVIEW
11.12.2 SWOT ANALYSIS
11.12.3 REVENUE ANALYSIS
11.12.4 PRODUCT PORTFOLIO
11.12.5 RECENT DEVELOPEMENTS
11.12.5 DATA BRIDGE ANALYSIS
11.13 GEORGIA-PACIFIC
11.13.1 COMPANY OVERVIEW
11.13.2 SWOT ANALYSIS
11.13.3 REVENUE ANALYSIS
11.13.4 PRODUCT PORTFOLIO
11.13.5 RECENT DEVELOPEMENTS
11.13.5 DATA BRIDGE ANALYSIS
11.14 HOGY MEDICAL
11.14.1 COMPANY OVERVIEW
11.14.2 SWOT ANALYSIS
11.14.3 REVENUE ANALYSIS
11.14.4 PRODUCT PORTFOLIO
11.14.5 RECENT DEVELOPEMENTS
11.14.5 DATA BRIDGE ANALYSIS
11.15 MOLNLYCKE HEALTH CARE AB
11.15.1 COMPANY OVERVIEW
11.15.2 SWOT ANALYSIS
11.15.3 REVENUE ANALYSIS
11.15.4 PRODUCT PORTFOLIO
11.15.5 RECENT DEVELOPEMENTS
11.15.5 DATA BRIDGE ANALYSIS
11.16 PAUL HARTMANN AG
11.16.1 COMPANY OVERVIEW
11.16.2 SWOT ANALYSIS
11.16.3 REVENUE ANALYSIS
11.16.4 PRODUCT PORTFOLIO
11.16.5 RECENT DEVELOPEMENTS
11.16.5 DATA BRIDGE ANALYSIS
11.17 PRECISION FABRICS GROUP, INC
11.17.1 COMPANY OVERVIEW
11.17.2 SWOT ANALYSIS
11.17.3 REVENUE ANALYSIS
11.17.4 PRODUCT PORTFOLIO
11.17.5 RECENT DEVELOPEMENTS
11.17.5 DATA BRIDGE ANALYSIS
11.18 DOMTAR CORPORATION
11.18.1 COMPANY OVERVIEW
11.18.2 SWOT ANALYSIS
11.18.3 REVENUE ANALYSIS
11.18.4 PRODUCT PORTFOLIO
11.18.5 RECENT DEVELOPEMENTS
11.18.5 DATA BRIDGE ANALYSIS
11.19 CARDINAL HEALTH
11.19.1 COMPANY OVERVIEW
11.19.2 SWOT ANALYSIS
11.19.3 REVENUE ANALYSIS
11.19.4 PRODUCT PORTFOLIO
11.19.5 RECENT DEVELOPEMENTS
11.19.5 DATA BRIDGE ANALYSIS
11.20 UNICHARM CORPORATION
11.20.1 COMPANY OVERVIEW
11.20.2 SWOT ANALYSIS
11.20.3 REVENUE ANALYSIS
11.20.4 PRODUCT PORTFOLIO
11.20.5 RECENT DEVELOPEMENTS
11.20.5 DATA BRIDGE ANALYSIS
11.21 KRATON PERFORMANCE POLYMERS INC.
11.21.1 COMPANY OVERVIEW
11.21.2 SWOT ANALYSIS
11.21.3 REVENUE ANALYSIS
11.21.4 PRODUCT PORTFOLIO
11.21.5 RECENT DEVELOPEMENTS
11.21.5 DATA BRIDGE ANALYSIS
11.22 WONDERFUL NONWOVEN COMPANY
11.22.1 COMPANY OVERVIEW
11.22.2 SWOT ANALYSIS
11.22.3 REVENUE ANALYSIS
11.22.4 PRODUCT PORTFOLIO
11.22.5 RECENT DEVELOPEMENTS
11.22.5 DATA BRIDGE ANALYSIS
12 APPENDIX
13 ABOUT DATA BRIDGE MARKET RESEARCH
